Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

EGX:CPCI Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	371.38	246.11	97.09	165.74	124.3	109.14
Depreciation & Amortization	22.28	19.84	15.94	-	-	0.65
Other Amortization	0.02	0.01	0.01	-	-	-
Other Operating Activities	-36.89	-3.08	-24.52	-113.92	37.95	-131.75
Operating Cash Flow	356.78	262.89	88.53	51.83	162.25	-21.96
Operating Cash Flow Growth	101.18%	196.96%	70.82%	-68.06%	-	-
Capital Expenditures	-207.11	-243.54	-79.07	-17.31	-23.68	-8.34
Sale of Property, Plant & Equipment	-	-	0.08	0	0.04	-
Investment in Securities	-	-0.84	-	15.86	-14.11	14.47
Other Investing Activities	19.44	12.8	2.85	4.94	2.62	2.28
Investing Cash Flow	-187.67	-231.58	-76.14	3.49	-35.13	8.41
Long-Term Debt Issued	-	133.88	144.31	-	-	-
Long-Term Debt Repaid	-	-50.76	-28.36	-	-	-
Net Debt Issued (Repaid)	-45.02	83.12	115.95	-	-	-
Common Dividends Paid	-138.17	-85.53	-100.82	-75.2	-77.73	-54.95
Financing Cash Flow	-183.19	-2.41	15.13	-75.2	-77.73	-54.95
Net Cash Flow	-14.07	28.9	27.51	-19.89	49.39	-68.5
Free Cash Flow	149.67	19.35	9.45	34.52	138.57	-30.3
Free Cash Flow Growth	76.92%	104.69%	-72.61%	-75.09%	-	-
Free Cash Flow Margin	8.77%	1.42%	0.94%	3.10%	13.05%	-3.00%
Free Cash Flow Per Share	10.02	1.30	0.63	2.31	9.28	-2.03
Cash Interest Paid	17.24	20.21	5.85	-	-	-
Cash Income Tax Paid	88.46	45.89	73.12	51.33	36.22	36.35
Levered Free Cash Flow	-	-55.03	57.94	-20.17	97.35	-51.72
Unlevered Free Cash Flow	-	-43.19	60.12	-20.17	97.35	-51.72
Change in Net Working Capital	-	-1.94	-75.27	122.91	-23.32	130.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.